Adjusted completion rate of HRQOL measures in gilteritinib vs placebo. (A) Adjusted completion rate of FACT-BMT measure in gilteritinib vs placebo groups across each time point. (B) Adjusted completion rate of FACT-Leu measure in gilteritinib vs placebo groups across each time point. (C) Adjusted completion rate of EQ-5D-5L measure in gilteritinib vs placebo groups across each time point.